Developer docs
API playgroundTry for free, no card

Search company profiles

Centerline Biomedical

Full company profile

uuid0000ppm

Namestring
Centerline Biomedical
Legal namestring
Centerline Biomedical, Inc.
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Centerline Biomedical is a Cleveland Clinic spin-out founded in 2014 that develops the Intra-Operative Positioning System (IOPS), an FDA 510(k)-cleared electromagnetic tracking-based 3D surgical navigation platform for endovascular procedures. The system builds a patient-specific 3D vascular model from pre-operative CT scans and tracks sensor-equipped catheters and guidewires in real time to provide GPS-like visualization of tip position, shape, and orientation, enabling navigation without continuous fluoroscopy or iodinated contrast. IOPS integrates with CBCT imaging systems from GE, Siemens, and Philips and includes proprietary Spintegration technology for intraoperative CBCT overlay. The company serves hospital vascular surgery departments performing complex aortic and peripheral endovascular procedures, with deployments at Cleveland Clinic, Massachusetts General Hospital, Vanderbilt, University of Virginia, Allegheny Health Network, Memorial Hermann, and other academic medical centers across the United States, and over 200 cumulative procedures documented as of May 2024.

The business model combines capital equipment sales of the IOPS platform (cart, tracking pad, field generator, software) with recurring revenue from single-use disposables including 6Fr Viewpoint Catheters and the IOPS Guidewire Handle. Distribution is direct enterprise sales to hospital vascular surgery and interventional radiology departments, supported by key opinion leader engagement, peer-reviewed clinical publications, and presence at major vascular conferences. Additional revenue and strategic optionality comes from military R&D collaborations with the USAF 59th Wing and US Army Institute of Surgical Research. The company has raised over $57 million across multiple funding rounds and holds three FDA clearances in the 2024-2025 period, indicating an active transition from R&D to commercial scaling, though no revenue is publicly disclosed.

Short descriptiontext

Centerline Biomedical is a Cleveland Clinic spin-out that markets IOPS, an FDA-cleared 3D electromagnetic navigation system for endovascular surgery that reduces radiation exposure. It sells capital equipment plus disposable catheters to U.S. hospital vascular surgery departments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCleveland, United States
HQ citystring
Cleveland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
endovascular navigation, surgical navigation systems, medical imaging devices, vascular surgery equipment, electromagnetic tracking
Industry3 codes
PRIMARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Navigation Systems
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1IOPS Navigation System Sales
TypeHardware Sales
Description

Sale of the IOPS hardware platform including the IOPS Cart, Tracking Pad, field generator, and sensor control unit. The system is marketed to hospital vascular surgery and endovascular procedure departments as capital equipment.

centerlinebiomedical.com
2IOPS Disposables (Catheters, Guidewires, Handles)
TypeHardware Sales
Description

Recurring revenue from single-use disposables including the 6Fr Viewpoint Catheters (Simple Curve and Double Curve variants), IOPS Guidewire Handle, and IOPS Fiducial Tracking Pad. These are consumable products used in each procedure.

centerlinebiomedical.com
3IOPS Software Licensing and Updates
TypeSubscription Recurring
Description

The IOPS software platform (V1.0 through V1.5) is provided as part of the system. Software updates and new versions (e.g., V1.4, V1.5) are released with new features. The software enables 3D model building, real-time navigation, Spintegration CBCT overlay, and multi-view display.

centerlinebiomedical.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1IOPS
Description

Intra-Operative Positioning System - FDA 510(k) cleared 3D endovascular navigation technology that reduces radiation exposure and improves accuracy during vascular procedures.

centerlinebiomedical.com
Core offering1 text field

Centerline Biomedical develops and commercializes the IOPS (Intra-Operative Positioning System), an FDA 510(k) cleared 3D surgical navigation platform for endovascular procedures. The system uses electromagnetic tracking combined with patient-specific 3D vascular models to provide real-time catheter and guidewire positioning without continuous fluoroscopy, reducing radiation exposure for both patients and surgical teams. Revenue is generated through capital equipment sales of the IOPS hardware platform and recurring sales of single-use disposable catheters and guidewire accessories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 46.6% reduction in vessel cannulation time using IOPS 3D navigation vs. traditional 2D fluoroscopy (in vitro study)
+6 more records
Product overview1 text field

Centerline Biomedical offers the IOPS (Intra-Operative Positioning System) platform, an FDA 510(k) cleared surgical navigation technology. The platform consists of the IOPS Software (current version V1.5), IOPS Fiducial Tracking Pad hardware, and compatible sensor-equipped disposable catheters including the Viewpoint Simple Curve and Double Curve catheters (6Fr), as well as the IOPS Guidewire Handle. These components work together to provide real-time 3D navigation, reduce radiation exposure, and improve visualization during endovascular procedures in peripheral, aortic, and aortic side branch vasculature.

Product and service6 records
1IOPS (Intra-Operative Positioning System)
CategoryCore Navigation Platform
Description

FDA 510(k) cleared 3D GPS-like surgical navigation and visualization technology for endovascular procedures. Provides real-time catheter and guidewire tip positioning within a patient-specific 3D vascular model generated from pre-operative CT scans, enabling navigation without continuous radiation exposure. Includes the IOPS Cart, Tracking Pad, field generator, and sensor control unit sold to hospital vascular surgery departments as capital equipment.

2IOPS Software
CategoryNavigation Software
Description

Surgical navigation software platform (current version V1.5) that builds 3D models from CT scans, displays multi-view anatomy via up to four concurrent 3D views, captures CBCT overlays through the Spintegration feature, and tracks IOPS catheter and guidewire positions in real time. Sold as part of the IOPS system with ongoing software version updates.

36Fr Viewpoint Simple Curve Catheter
CategoryDisposable Catheter
Description

Single-use sensor-equipped navigation catheter with 75cm or 125cm working length, 0.035 inch guidewire compatibility, and a 75 degree curve designed for standard endovascular procedures. Provides reliable pushability and 1:1 torque control. Recurring disposable consumable used with the IOPS platform.

46Fr Viewpoint Double Curve Catheter
CategoryDisposable Catheter
Description

Single-use sensor-equipped navigation catheter with 75cm or 125cm working length and a 133 degree curve to distal tip, designed for navigating tortuous anatomy. Recurring disposable consumable used with the IOPS platform.

5IOPS Guidewire Handle
CategoryDisposable Accessory
Description

FDA 510(k) cleared guidewire handle accessory for the IOPS platform that enables sensor-equipped guidewire navigation with enhanced control during endovascular procedures.

6IOPS Fiducial Tracking Pad
CategoryHardware Component
Description

Hardware component of the IOPS platform that enables electromagnetic tracking of catheter and guidewire positions during procedures by serving as the field generator reference.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Arnaud Marie (Board Advisor)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-08-16
Description

Arnaud Marie, General Manager for Global Interventional at GE Healthcare with more than 26 years in the healthcare industry, joined as a Board advisor bringing breadth of experiences in MedTech. Represents a strategic advisory relationship with access to GE Healthcare's industry expertise.

centerlinebiomedical.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-05-11
Description

Development collaboration for novel augmented reality system leveraging AR technology and novel nanoparticles for trauma resuscitation applications, in partnership with US military medical research institutions.

3USA Air Force (59th Wing)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-01
Description

R&D collaboration with the USAF 59th Wing focused on surgical navigation technology. The collaboration was noted as part of the company's mission to reduce radiation exposure in surgical settings, with potential defense medical applications.

centerlinebiomedical.com
4USA Army Institute of Surgical Research (ISR)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-01
Description

Collaboration with USA Army ISR for trauma resuscitation and novel augmented reality navigation system development. Part of development of novel systems leveraging AR technology for military medical applications.

centerlinebiomedical.com
5Dr. Azeem Latib and Doug Teany (Clinical Advisors)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-06-21
Description

Dr. Azeem Latib (coronary interventions) and Doug Teany joined as expert advisors to advance new clinical applications, bringing deep subject matter expertise in coronary and structural heart interventions for IOPS platform expansion.

centerlinebiomedical.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2014-11-01
Description

Cleveland Clinic is the originating institution and co-founder of Centerline Biomedical. Centerline is a joint venture of G2 Group Ventures and Cleveland Clinic, with Cleveland Clinic originally developing the IOPS technology. The relationship includes technology licensing, clinical research collaboration (preclinical and clinical studies), and investment/follow-on funding. Key opinion leaders from Cleveland Clinic (Dr. Matthew Eagleton, Dr. Ezequiel Parodi) serve on the Scientific Advisory Board.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Brainlab offers image-guided surgery and surgical navigation platforms across multiple specialties. While it focuses heavily on neurosurgery, ENT, and orthopedics, its 3D navigation, intraoperative imaging integration, and software architecture are directly comparable to Centerline's IOPS approach in endovascular procedures.

TypeBroad incumbent
Description

Medtronic's StealthStation surgical navigation system and broader cranial/spine navigation portfolio represent the dominant incumbent in image-guided surgery. As a diversified medtech giant with a large capital equipment sales force, Medtronic could extend or compete with Centerline in vascular navigation.

TypeBroad incumbent
Description

Stryker's navigation and guidance solutions (acquired with MAKO Surgical and other assets) target orthopedic and ENT surgical navigation. As a large diversified medtech with significant R&D and commercial scale, Stryker is a potential competitor or acquirer in the surgical navigation space.

TypeBroad incumbent
Description

Siemens is a major OEM provider of CBCT imaging systems (ARTIS) used in endovascular procedures, and one of the three CBCT vendors that IOPS integrates with. Siemens has the scale and installed base to develop or bundle competing navigation capabilities.

TypeBroad incumbent
Description

GE Healthcare provides the Innova CBCT imaging systems that IOPS integrates with and is also a Series B investor in Centerline. As an OEM with a large interventional imaging business, GE represents both a critical integration partner and a potential competitive threat.

TypeBroad incumbent
Description

Philips' Azurion image-guided therapy platform is a leading CBCT and endovascular imaging system and is the third major OEM that IOPS integrates with. Philips has the commercial scale and clinical relationships to either partner with or compete against Centerline in vascular navigation.

7Corindus (Siemens Healthineers)
TypeDirect peer
Description

Corindus develops robotic-assisted platforms for endovascular procedures, offering precise catheter and guidewire manipulation. As the only commercial vascular robotics platform, it represents the most direct adjacent technology competitor to IOPS navigation.

TypeEmerging player
Description

Penumbra is a high-growth endovascular device company focused on thrombectomy, embolization, and other vascular interventions. While not a navigation platform, Penumbra serves the same hospital vascular surgery and interventional radiology customers and could expand into navigation-adjacent capabilities.

TypeEmerging player
Description

7D Surgical develops machine-vision-based surgical navigation systems for spine and cranial procedures. As a smaller navigation-focused competitor, it represents a similar technology and commercial approach in adjacent surgical specialties.

TypeOthers
Description

HeartFlow provides non-invasive FFR-CT analysis for cardiovascular disease, reducing the need for invasive diagnostic catheterization. While not a direct navigation competitor, HeartFlow is thematically adjacent in the effort to reduce radiation and invasiveness in cardiovascular care.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature13 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Centerline Biomedical

Surgical Navigation Systemscenterlinebiomedical.com

Centerline Biomedical is a Cleveland Clinic spin-out that markets IOPS, an FDA-cleared 3D electromagnetic navigation system for endovascular surgery that reduces radiation exposure. It sells capital equipment plus disposable catheters to U.S. hospital vascular surgery departments.

What Centerline Biomedical does

Centerline Biomedical is a Cleveland Clinic spin-out founded in 2014 that develops the Intra-Operative Positioning System (IOPS), an FDA 510(k)-cleared electromagnetic tracking-based 3D surgical navigation platform for endovascular procedures. The system builds a patient-specific 3D vascular model from pre-operative CT scans and tracks sensor-equipped catheters and guidewires in real time to provide GPS-like visualization of tip position, shape, and orientation, enabling navigation without continuous fluoroscopy or iodinated contrast. IOPS integrates with CBCT imaging systems from GE, Siemens, and Philips and includes proprietary Spintegration technology for intraoperative CBCT overlay. The company serves hospital vascular surgery departments performing complex aortic and peripheral endovascular procedures, with deployments at Cleveland Clinic, Massachusetts General Hospital, Vanderbilt, University of Virginia, Allegheny Health Network, Memorial Hermann, and other academic medical centers across the United States, and over 200 cumulative procedures documented as of May 2024.

The business model combines capital equipment sales of the IOPS platform (cart, tracking pad, field generator, software) with recurring revenue from single-use disposables including 6Fr Viewpoint Catheters and the IOPS Guidewire Handle. Distribution is direct enterprise sales to hospital vascular surgery and interventional radiology departments, supported by key opinion leader engagement, peer-reviewed clinical publications, and presence at major vascular conferences. Additional revenue and strategic optionality comes from military R&D collaborations with the USAF 59th Wing and US Army Institute of Surgical Research. The company has raised over $57 million across multiple funding rounds and holds three FDA clearances in the 2024-2025 period, indicating an active transition from R&D to commercial scaling, though no revenue is publicly disclosed.

Centerline Biomedical firmographics

Firmographics
Name
Centerline Biomedical
Legal name
Centerline Biomedical, Inc.
Website
https://centerlinebiomedical.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Centerline Biomedical is a Cleveland Clinic spin-out that markets IOPS, an FDA-cleared 3D electromagnetic navigation system for endovascular surgery that reduces radiation exposure. It sells capital equipment plus disposable catheters to U.S. hospital vascular surgery departments.
Ownership category
akta.pro rank

Centerline Biomedical industry classification

Industry
Product category
Surgical Navigation Systems
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Endovascular navigation
  • Surgical navigation systems
  • Medical imaging devices
  • Vascular surgery equipment
  • Electromagnetic tracking

Where Centerline Biomedical is headquartered

Location

Headquarters

HQ city
Cleveland
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Centerline Biomedical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others

Revenue model

  1. IOPS Navigation System Sales: Sale of the IOPS hardware platform including the IOPS Cart, Tracking Pad, field generator, and sensor control unit. The system is marketed to hospital vascular surgery and endovascular procedure departments as capital equipment.
  2. IOPS Disposables (Catheters, Guidewires, Handles): Recurring revenue from single-use disposables including the 6Fr Viewpoint Catheters (Simple Curve and Double Curve variants), IOPS Guidewire Handle, and IOPS Fiducial Tracking Pad. These are consumable products used in each procedure.
  3. IOPS Software Licensing and Updates: The IOPS software platform (V1.0 through V1.5) is provided as part of the system. Software updates and new versions (e.g., V1.4, V1.5) are released with new features. The software enables 3D model building, real-time navigation, Spintegration CBCT overlay, and multi-view display.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels10 records

Centerline Biomedical product offering

Product offering

Core offering

Centerline Biomedical develops and commercializes the IOPS (Intra-Operative Positioning System), an FDA 510(k) cleared 3D surgical navigation platform for endovascular procedures. The system uses electromagnetic tracking combined with patient-specific 3D vascular models to provide real-time catheter and guidewire positioning without continuous fluoroscopy, reducing radiation exposure for both patients and surgical teams. Revenue is generated through capital equipment sales of the IOPS hardware platform and recurring sales of single-use disposable catheters and guidewire accessories.

Product overview

Centerline Biomedical offers the IOPS (Intra-Operative Positioning System) platform, an FDA 510(k) cleared surgical navigation technology. The platform consists of the IOPS Software (current version V1.5), IOPS Fiducial Tracking Pad hardware, and compatible sensor-equipped disposable catheters including the Viewpoint Simple Curve and Double Curve catheters (6Fr), as well as the IOPS Guidewire Handle. These components work together to provide real-time 3D navigation, reduce radiation exposure, and improve visualization during endovascular procedures in peripheral, aortic, and aortic side branch vasculature.

Differentiator

Problem solved

Functional benefit

Brands

  • IOPS: Intra-Operative Positioning System - FDA 510(k) cleared 3D endovascular navigation technology that reduces radiation exposure and improves accuracy during vascular procedures.

Products and services

  • IOPS (Intra-Operative Positioning System) FDA 510(k) cleared 3D GPS-like surgical navigation and visualization technology for endovascular procedures. Provides real-time catheter and guidewire tip positioning within a patient-specific 3D vascular model generated from pre-operative CT scans, enabling navigation without continuous radiation exposure. Includes the IOPS Cart, Tracking Pad, field generator, and sensor control unit sold to hospital vascular surgery departments as capital equipment.
  • IOPS Software Surgical navigation software platform (current version V1.5) that builds 3D models from CT scans, displays multi-view anatomy via up to four concurrent 3D views, captures CBCT overlays through the Spintegration feature, and tracks IOPS catheter and guidewire positions in real time. Sold as part of the IOPS system with ongoing software version updates.
  • 6Fr Viewpoint Simple Curve Catheter Single-use sensor-equipped navigation catheter with 75cm or 125cm working length, 0.035 inch guidewire compatibility, and a 75 degree curve designed for standard endovascular procedures. Provides reliable pushability and 1:1 torque control. Recurring disposable consumable used with the IOPS platform.
  • 6Fr Viewpoint Double Curve Catheter Single-use sensor-equipped navigation catheter with 75cm or 125cm working length and a 133 degree curve to distal tip, designed for navigating tortuous anatomy. Recurring disposable consumable used with the IOPS platform.
  • IOPS Guidewire Handle FDA 510(k) cleared guidewire handle accessory for the IOPS platform that enables sensor-equipped guidewire navigation with enhanced control during endovascular procedures.
  • IOPS Fiducial Tracking Pad Hardware component of the IOPS platform that enables electromagnetic tracking of catheter and guidewire positions during procedures by serving as the field generator reference.

Quantifiable outcome

  • 46.6% reduction in vessel cannulation time using IOPS 3D navigation vs. traditional 2D fluoroscopy (in vitro study)
  • +6 more outcomes

Companies that use Centerline Biomedical

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles1 record

Centerline Biomedical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature13 records

Centerline Biomedical partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor, core and flagship.

  • Arnaud Marie (Board Advisor)minorStrategic or Co-development Partner · 16 August 2022Arnaud Marie, General Manager for Global Interventional at GE Healthcare with more than 26 years in the healthcare industry, joined as a Board advisor bringing breadth of experiences in MedTech. Represents a strategic advisory relationship with access to GE Healthcare's industry expertise.
  • Augmented Reality Technology Collaboration (for trauma resuscitation)minorStrategic or Co-development Partner · 11 May 2022Development collaboration for novel augmented reality system leveraging AR technology and novel nanoparticles for trauma resuscitation applications, in partnership with US military medical research institutions.
  • USA Air Force (59th Wing)coreStrategic or Co-development Partner · 1 May 2022R&D collaboration with the USAF 59th Wing focused on surgical navigation technology. The collaboration was noted as part of the company's mission to reduce radiation exposure in surgical settings, with potential defense medical applications.
  • USA Army Institute of Surgical Research (ISR)coreStrategic or Co-development Partner · 1 May 2022Collaboration with USA Army ISR for trauma resuscitation and novel augmented reality navigation system development. Part of development of novel systems leveraging AR technology for military medical applications.
  • Dr. Azeem Latib and Doug Teany (Clinical Advisors)minorStrategic or Co-development Partner · 21 June 2021Dr. Azeem Latib (coronary interventions) and Doug Teany joined as expert advisors to advance new clinical applications, bringing deep subject matter expertise in coronary and structural heart interventions for IOPS platform expansion.
  • Cleveland ClinicflagshipStrategic or Co-development Partner · 1 November 2014Cleveland Clinic is the originating institution and co-founder of Centerline Biomedical. Centerline is a joint venture of G2 Group Ventures and Cleveland Clinic, with Cleveland Clinic originally developing the IOPS technology. The relationship includes technology licensing, clinical research collaboration (preclinical and clinical studies), and investment/follow-on funding. Key opinion leaders from Cleveland Clinic (Dr. Matthew Eagleton, Dr. Ezequiel Parodi) serve on the Scientific Advisory Board.

Scale indicators11 records

Recent moves7 records

Expansion highlights7 records

Centerline Biomedical competitors and assessment

Company assessment

Direct peers

  • Brainlab: Brainlab offers image-guided surgery and surgical navigation platforms across multiple specialties. While it focuses heavily on neurosurgery, ENT, and orthopedics, its 3D navigation, intraoperative imaging integration, and software architecture are directly comparable to Centerline's IOPS approach in endovascular procedures.
  • Corindus (Siemens Healthineers): Corindus develops robotic-assisted platforms for endovascular procedures, offering precise catheter and guidewire manipulation. As the only commercial vascular robotics platform, it represents the most direct adjacent technology competitor to IOPS navigation.

Broad incumbents

  • Medtronic: Medtronic's StealthStation surgical navigation system and broader cranial/spine navigation portfolio represent the dominant incumbent in image-guided surgery. As a diversified medtech giant with a large capital equipment sales force, Medtronic could extend or compete with Centerline in vascular navigation.
  • Stryker: Stryker's navigation and guidance solutions (acquired with MAKO Surgical and other assets) target orthopedic and ENT surgical navigation. As a large diversified medtech with significant R&D and commercial scale, Stryker is a potential competitor or acquirer in the surgical navigation space.
  • Siemens Healthineers: Siemens is a major OEM provider of CBCT imaging systems (ARTIS) used in endovascular procedures, and one of the three CBCT vendors that IOPS integrates with. Siemens has the scale and installed base to develop or bundle competing navigation capabilities.
  • GE Healthcare: GE Healthcare provides the Innova CBCT imaging systems that IOPS integrates with and is also a Series B investor in Centerline. As an OEM with a large interventional imaging business, GE represents both a critical integration partner and a potential competitive threat.
  • Philips: Philips' Azurion image-guided therapy platform is a leading CBCT and endovascular imaging system and is the third major OEM that IOPS integrates with. Philips has the commercial scale and clinical relationships to either partner with or compete against Centerline in vascular navigation.

Emerging players

  • Penumbra: Penumbra is a high-growth endovascular device company focused on thrombectomy, embolization, and other vascular interventions. While not a navigation platform, Penumbra serves the same hospital vascular surgery and interventional radiology customers and could expand into navigation-adjacent capabilities.
  • 7D Surgical: 7D Surgical develops machine-vision-based surgical navigation systems for spine and cranial procedures. As a smaller navigation-focused competitor, it represents a similar technology and commercial approach in adjacent surgical specialties.

Others

  • HeartFlow: HeartFlow provides non-invasive FFR-CT analysis for cardiovascular disease, reducing the need for invasive diagnostic catheterization. While not a direct navigation competitor, HeartFlow is thematically adjacent in the effort to reduce radiation and invasiveness in cardiovascular care.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Centerline Biomedical social profiles

Digital presence

Centerline Biomedical compliance and trust

Trust signal

Compliance1 record

Centerline Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Centerline Biomedical leadership team

Management profile

Number of profiles

Profiles4 records

Centerline Biomedical funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Centerline Biomedical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centerline Biomedical

What does Centerline Biomedical do?

Centerline Biomedical develops and commercializes the IOPS (Intra-Operative Positioning System), an FDA 510(k) cleared 3D surgical navigation platform for endovascular procedures. The system uses electromagnetic tracking combined with patient-specific 3D vascular models to provide real-time catheter and guidewire positioning without continuous fluoroscopy, reducing radiation exposure for both patients and surgical teams. Revenue is generated through capital equipment sales of the IOPS hardware platform and recurring sales of single-use disposable catheters and guidewire accessories.

Is Centerline Biomedical a public or private company?

Centerline Biomedical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Centerline Biomedical founded?

Centerline Biomedical was founded in 2014. It employs 11 to 50 people.

Where is Centerline Biomedical based?

Centerline Biomedical is headquartered in Cleveland, United States, in the North America region.

How does Centerline Biomedical make money?

Three revenue lines are on record. IOPS Navigation System Sales are the primary driver. The others are IOPS Disposables (Catheters, Guidewires, Handles) and IOPS Software Licensing and Updates.

Who are Centerline Biomedical's main competitors?

Direct peers on record are Brainlab and Corindus (Siemens Healthineers). Broad incumbents are Medtronic, Stryker, Siemens Healthineers, GE Healthcare and Philips. Emerging players are Penumbra and 7D Surgical. HeartFlow is listed as an others.

Does Centerline Biomedical have an API?

No public API is recorded for Centerline Biomedical.

What industry is Centerline Biomedical in?

Centerline Biomedical's product category is Surgical Navigation Systems. Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireCenterline Biomedical to Debut IOPS Visionary™ at VEITHsymposium, Showcasing the Next Generation of 3D EV NavigationCenterline Biomedical will debut IOPS Visionary at VEITHsymposium, its first public showing of the 510(k)-cleared platform. The system provides real-time electromagnetic device tracking and 3D visualization for endovascular navigation. The debut aims to reduce fluoroscopy use and radiation exposure during complex interventions.EIN PresswireCenterline Biomedical to Debut IOPS Visionary™ at VEITHsymposium, Showcasing the Next Generation of 3D EV NavigationCenterline Biomedical will debut IOPS Visionary at VEITHsymposium 2026, its first public showing of the 510(k)-cleared 3D endovascular navigation platform. The system adds real-time device tracking, 3D visualization, and live fluoroscopic overlay to conventional fluoroscopy. The company plans to continue developing the platform for broader transcatheter applications.EIN PresswireCenterline Biomedical Introduces IOPS Visionary™, Its Next-Generation 3D Endovascular Navigation PlatformCenterline Biomedical introduced IOPS Visionary, a 510(k)-cleared 3D endovascular navigation platform with real-time electromagnetic tracking and 3D visualization. It integrates cone-beam CT updates and live fluoroscopy, aiming to reduce radiation exposure during complex interventions. The system will be showcased at the 2026 VEITHsymposium in New York City.EIN PresswireCenterline Biomedical Introduces IOPS Visionary™, Its Next-Generation 3D Endovascular Navigation PlatformCenterline Biomedical introduced IOPS Visionary, a 510(k)-cleared 3D endovascular navigation platform with real-time electromagnetic tracking and 3D visualization. It integrates cone-beam CT updates and live fluoroscopy, aiming to reduce radiation exposure during complex interventions. The system will be showcased at the 2026 VEITHsymposium in New York City.Crain's Cleveland BusinessCenterline Biomedical appoints new president and CEOCenterline Biomedical, Inc. has appointed Jim Dillon as its new president and CEO, effective August 18, 2025, replacing Gulam Khan. This leadership change occurs at the Cleveland-based medical technology company known for its Intra-Operative Positioning System. The appointment represents a routine executive transition within the firm.MedTech DiveCenterline recalls guidewire over risk of coating being left in patientsCenterline Biomedical has initiated a Class I recall of its IOPS Guidewire ATW-2 devices after the coating was found to potentially delaminate and remain inside patients during vascular procedures. The Food and Drug Administration issued the notice due to the risk of serious injury or death, although no injuries have been reported so far and only 80 units are affected across eight states.Cleveland ClinicImage of Note: 3-D Radiation-Free Navigation of the AortaCleveland Clinic's Centerline Biomedical is refining its Intraoperative Positioning System (IOPS) for endovascular aortic repair navigation. A preclinical study in May 2016 showed IOPS provides radiation-free visualization superior to X-ray fluoroscopy. The company plans FDA review with a target market entry in Q3 2017.MorningstarGrowing Market Applications, Centerline Biomedical Granted FDA 510(k) Clearance for IOPS® with New, Expanded Indication for UseCenterline Biomedical received FDA 510(k) clearance for expanded indications of its IOPS intra-operative positioning system, including use in peripheral, aortic, and aortic side branch vasculature. The clearance also covers a second-generation IOPS Fiducial Tracking Pad, broadening the platform's clinical applications.Business Wire BlogGrowing Market Applications, Centerline Biomedical Granted FDA 510(k) Clearance for IOPS® with New, Expanded Indication for UseCenterline Biomedical received FDA 510(k) clearance for expanded indications of its IOPS intra-operative positioning system, including use in peripheral, aortic, and aortic side branch vasculature. The clearance also covers the IOPS Fiducial Tracking Pad, a second-generation device. The company aims to reduce fluoroscopy reliance and radiation exposure in endovascular procedures.Cleveland ClinicWhen Two Fields Collide: One Biomedical Engineer’s Passion to Innovate Surgical CareKarl West, Director of Medical Device Solutions at Cleveland Clinic, discusses the application of biomedical engineering to transform surgical care through technologies like Microsoft HoloLens and 3D printing. The article highlights specific innovations such as a 3D GPS-like surgical navigation tool that reduces radiation exposure, which was spun off as Centerline Biomedical, and MediView XR, a startup focused on holographic guidance for lesion ablation.